Ornidazole: Difference between revisions
No edit summary |
Kiran Singh (talk | contribs) No edit summary |
||
(2 intermediate revisions by one other user not shown) | |||
Line 19: | Line 19: | ||
}} | }} | ||
__Notoc__ | |||
{{SI}} | {{SI}} | ||
{{CMG}} | |||
==Overview== | |||
'''Ornidazole''' is a drug that cures some [[protozoan]] infections. | |||
== | It has been investigated for use in [[Crohn's disease]] after bowel resection.<ref name="pmid15825069">{{cite journal |author=Rutgeerts P, Van Assche G, Vermeire S, ''et al.'' |title=Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial |journal=Gastroenterology |volume=128 |issue=4 |pages=856–61 |date=April 2005 |pmid=15825069 |doi= 10.1053/j.gastro.2005.01.010|url=http://linkinghub.elsevier.com/retrieve/pii/S0016508505000302}}</ref> | ||
'''Ornidazole' | |||
==References== | |||
{{reflist|2}} | |||
{{Gynecological anti-infectives and antiseptics}} | {{Gynecological anti-infectives and antiseptics}} | ||
{{Other antibacterials}} | {{Other antibacterials}} | ||
{{Agents against amoebiasis and other protozoal diseases}} | {{Agents against amoebiasis and other protozoal diseases}} | ||
[[Category:Antiprotozoal agents]] | [[Category:Antiprotozoal agents]] |
Latest revision as of 18:41, 7 April 2015
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code | |
Pharmacokinetic data | |
Metabolism | Metabolised via the liver, excreted in the Urine and Feces |
Excretion | 85% of single oral dose is elimiated with 5 days - Urine (63%) and Feces (22%) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C7H10ClN3O3 |
Molar mass | 219.625 |
WikiDoc Resources for Ornidazole |
Articles |
---|
Most recent articles on Ornidazole |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Ornidazole at Clinical Trials.gov Clinical Trials on Ornidazole at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Ornidazole
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Ornidazole Discussion groups on Ornidazole Patient Handouts on Ornidazole Directions to Hospitals Treating Ornidazole Risk calculators and risk factors for Ornidazole
|
Healthcare Provider Resources |
Causes & Risk Factors for Ornidazole |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Ornidazole is a drug that cures some protozoan infections.
It has been investigated for use in Crohn's disease after bowel resection.[1]
References
- ↑ Rutgeerts P, Van Assche G, Vermeire S; et al. (April 2005). "Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial". Gastroenterology. 128 (4): 856–61. doi:10.1053/j.gastro.2005.01.010. PMID 15825069.
Template:Other antibacterials Template:Agents against amoebiasis and other protozoal diseases
- Pages with script errors
- CS1 maint: Explicit use of et al.
- CS1 maint: Multiple names: authors list
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Antiprotozoal agents
- Poultry diseases